OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting homologous recombination deficiency in uterine leiomyosarcoma
Genevieve Dall, Cassandra J. Vandenberg, Ksenija Nesic, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 14

Showing 14 citing articles:

Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy
Qiwei Yang, Obianuju Sandra Madueke-Laveaux, Han Cun, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1106-1106
Open Access | Times Cited: 5

Application of patient derived xenograft model in personalized drug screening for chondrosarcoma of head and neck: A preclinical study
Yufei Hua, Zhiyong Guo, Ying Wang, et al.
Oral Oncology (2025) Vol. 162, pp. 107222-107222
Closed Access

Pathogenic germline variants among women with uterine cancer by ancestry: A commercial laboratory collaborative research registry study
Caitlin Ruth Johnson, Chinmayi Aryasomayajula, Alex Francoeur, et al.
Gynecologic Oncology (2025) Vol. 197, pp. 83-90
Closed Access

Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches
Alice Costa, Annalisa Astolfi, Livia Gozzellino, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 265-265
Open Access

The Future of Targeted Therapy for Leiomyosarcoma
Ryan A. Denu, Amanda M. Dann, Emily Z. Keung, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 938-938
Open Access | Times Cited: 3

Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with Sarcoma
Eden C. Andrew, Jeremy Lewin, Jayesh Desai, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 128-128
Open Access | Times Cited: 2

Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis
Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. 560-565
Open Access | Times Cited: 2

PARP inhibitors in non-ovarian gynecologic cancers
Ítalo Fernandes, Rania Chehade, Helen Mackay
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2

Clinical characteristics and treatment outcomes of women with recurrent uterine leiomyosarcoma
Hua Yuan, Yaxi Wang, Ning Li, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1

Clinical Impact of Comprehensive Molecular Profiling in Adolescent and Young Adults with Sarcoma
Eden C. Andrew, Jeremy Lewin, Jayesh Desai, et al.
(2023)
Open Access | Times Cited: 1

Molecular Heterogeneity in Leiomyosarcoma and Implications for Personalised Medicine
Sara Arfan, Khin Thway, Robin L. Jones, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 5, pp. 644-658
Closed Access

Carboplatin/dacarbazine/olaparib

Reactions Weekly (2023) Vol. 1984, Iss. 1, pp. 144-144
Closed Access

Page 1

Scroll to top